Poly(oxy-1,2-ethanediyl), I+/--[3-(2,5-dihydro-4-methyl-2,5-dioxofuran-3-yl)-1-oxopropyl]-I-methoxy- | 844503-45-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Poly(oxy-1,2-ethanediyl), I+/--[3-(2,5-dihydro-4-methyl-2,5-dioxofuran-3-yl)-1-oxopropyl]-I-methoxy-
• 英文别名: 2-methoxyethyl 3-(4-methyl-2,5-dioxofuran-3-yl)propanoate
• CAS: 844503-45-3
• 化学式: C₁₁H₁₄O₆
• 分子量: 242.22
• InChiKey: NNRYUQVGHBDINH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  78.9
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• Compositions for Targeted Delivery of siRNA
  申请人：Rozema David B.

  公开号：US20110207799A1

  公开（公告）日：2011-08-25

  The present invention is directed compositions for targeted delivery of RNA interference (RNAi) polynucleotides to hepatocytes in vivo. Targeted RNAi polynucleotides are administered together with co-targeted delivery polymers. Delivery polymers provide membrane penetration function for movement of the RNAi polynucleotides from outside the cell to inside the cell. Reversible modification provides physiological responsiveness to the delivery polymers.

  本发明涉及用于靶向递送RNA干扰（RNAi）多核苷酸至体内肝细胞的组合物。靶向RNAi多核苷酸与共靶向递送聚合物一起给予。递送聚合物提供膜穿透功能，用于将RNAi多核苷酸从细胞外运送到细胞内。可逆修饰为递送聚合物提供生理响应性。
• GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA
  申请人：Hadwiger Philipp

  公开号：US20120157509A1

  公开（公告）日：2012-06-21

  The present invention is directed compositions for targeted delivery of RNA interference (RNAi) polynucleotides to cell in vivo. The pharmacokinetic modulator improve in vivo targeting compared to the targeting ligand alone. Targeting ligand-pharmacokinetic modulator targeting moiety targeted RNAi polynucleotides can be administered in vivo alone or together with co-targeted delivery polymers.

  本发明涉及用于靶向递送RNA干扰（RNAi）多核苷酸至体内细胞的组合物。与单独的靶向配体相比，药代动力学调节剂改善了体内靶向。靶向配体-药代动力学调节剂靶向基团靶向的RNAi多核苷酸可以单独或与共靶向递送聚合物一起在体内给予。
• POLY(AMIDE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES
  申请人：Barrett Stephanie E.

  公开号：US20130253135A1

  公开（公告）日：2013-09-26

  The present invention provides poly(amide) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.

  本发明提供了用于治疗目的的寡核苷酸传递的聚酰胺聚合物，聚共轭物，组成物和方法。
• RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
  申请人：SIRNA THERAPEUTICS, INC.

  公开号：US20160264964A1

  公开（公告）日：2016-09-15

  The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity, and/or modulate a gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against target gene expression.

  本发明涉及化合物、组合物以及方法，用于研究、诊断和治疗对基因表达和/或活性调节有反应并/或调节基因表达途径的特征、疾病和状况。具体而言，本发明涉及双链核酸分子，包括小核酸分子，如短干扰核酸（siNA）分子，能够介导或介导靶基因表达的RNA干扰（RNAi）。
• Galactose Cluster-Pharmacokinetic Modulator Targeting Moiety for siRNA
  申请人：Arrowhead Madison Inc.

  公开号：US20160102120A1

  公开（公告）日：2016-04-14

  The present invention is directed compositions for targeted delivery of RNA interference (RNAi) polynucleotides to cell in vivo. The pharmacokinetic modulator improve in vivo targeting compared to the targeting ligand alone. Targeting ligand-pharmacokinetic modulator targeting moiety targeted RNAi polynucleotides can be administered in vivo alone or together with co-targeted delivery polymers.

  本发明涉及用于靶向RNA干扰（RNAi）多核苷酸的组成物，以在体内将其传递至细胞。药代动力学调节剂可提高体内靶向性，相较于仅使用靶向配体。靶向配体-药代动力学调节剂靶向基团靶向RNAi多核苷酸可以单独或与共靶向递送聚合物一起在体内给予。